Voyager Therapeutics Company
Voyager Therapeutics is a gene therapy company developing treatments for fatal and debilitating diseases of the central nervous system
Industry:
Biotechnology, Health Care, Science and Engineering
Technology:
Neurological Disorders
Funding Status:
IPO
Investment Stage:
N/A
Estimated Revenue:
$10M to $50M
Investors Number:
7
Headquarters:
Cambridge, Massachusetts, United States
Employee Number:
101-250
Number Of Exists:
Series B
Investor Type:
Company
Total Funding:
135000000
Founded Date:
01 01 13
Last Funding Type:
Series B
Last Funding Date:
13 04 15